<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Robles | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/cloverbaboon4/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/cloverbaboon4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Robles.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b75be0b4f716c024c1d3f0ce438135e8</guid>
				<title>Robles posted an update: Oral squamous cell carcinoma (OSCC) is a general oral [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42759/</link>
				<pubDate>Sun, 09 Feb 2025 11:13:06 -0800</pubDate>

									<content:encoded><![CDATA[<p>Oral squamous cell carcinoma (OSCC) is a general oral disease with high mortality. This study aimed to investigate the effects and underlying mechanism of propofol in OSCC. Propofol treatment inhibited cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT), but promoted apoptosis and induced cell cycle arrest in OSCC&hellip;<span class="activity-read-more" id="activity-read-more-42759"><a href="http://www.nationalboardinstitute.com/activity/p/42759/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2c55f2829d173d96b9a3e4146df24dd1</guid>
				<title>Robles posted an update: The Task Force on Research Specific to Pregnant Women and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38355/</link>
				<pubDate>Tue, 04 Feb 2025 11:07:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>The Task Force on Research Specific to Pregnant Women and Lactating Women was established by the 21st Century Cures Act and charged with providing advice and guidance to the Secretary of Health and Human Services on activities related to identifying and addressing gaps in knowledge and research on safe and effective therapies for pregnant women&hellip;<span class="activity-read-more" id="activity-read-more-38355"><a href="http://www.nationalboardinstitute.com/activity/p/38355/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9ba354def3effddc372b790a92b588d9</guid>
				<title>Robles posted an update: While immunotherapy has revolutionized the treatment of many [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29938/</link>
				<pubDate>Tue, 28 Jan 2025 14:24:55 -0800</pubDate>

									<content:encoded><![CDATA[<p>While immunotherapy has revolutionized the treatment of many types of advanced cancer, most patients still do not derive benefit. The currently available immune checkpoint inhibitors target the adaptive immune system, generating a T-cell antitumor response. However, an antitumor immune response depends on a complex interplay of both innate and&hellip;<span class="activity-read-more" id="activity-read-more-29938"><a href="http://www.nationalboardinstitute.com/activity/p/29938/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5ff3e42c3f77e71a233a3e639689b0fb</guid>
				<title>Robles became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29931/</link>
				<pubDate>Tue, 28 Jan 2025 14:24:02 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>